Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles

By Genre D.   Protière C.   Macquart-Moulin G.   Gravis G.   Camerlo J.   Alzieu C.   Maraninchi D.   Moatti J-P.   Viens P.  

Supportive Care in Cancer, Vol. 10, Iss. 3, 2002-04 ,pp. : 222-230

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life after adjuvant chemotherapy for breast cancer

By Broeckel J.A.   Jacobsen P.B.   Balducci L.   Horton J.   Lyman G.H.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

By Svane Inge M.   Homburg Keld M.   Kamby Claus   Nielsen Dorte L.   Roer Ole   Sliffsgaard Dorte   Johnsen Hans E.   Hansen Steen W.  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite

Economic Analyses of Toxicity Secondary to Anthracycline-based Breast Cancer Chemotherapy

By Dranitsaris G.   Tran T.M.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2174-2180

Elsevier

Access to resources Recommend Favorite

Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer

By Lindman Henrik   Åström Gunnar   Ahlgren Johan   Villman Kenneth   Blomqvist Carl   Nygren Peter   Bergh Jonas  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 165-171

Informa Healthcare

Access to resources Recommend Favorite